The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and trospium chloride), a first-in-class muscarinic ...

A 61-year-old man allegedly stabbed Sunday night by his 26-year-old son in Pearl City told police his son suffers from ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

Among individuals with schizophrenia, the risk for natural-cause mortality was increased in those with reduced cognitive functioning.

A new study links hallucinogen-related emergency department visits to a 21-fold increased risk of schizophrenia compared to ...

ED visits related to hallucinogen use are linked to a 21-fold increased risk of schizophrenia spectrum disorder, results of a ...

Individuals with emergency department visits involving hallucinogen use are at high risk of developing schizophrenia, ...

Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...

New research highlights neuroglia (or glia cells) as critical players in mental health, potentially influencing conditions like depression and schizophrenia.

AbbVie Inc.’s disappointing trial results for its new schizophrenia drug bode well for rival Bristol Myers Squibb Co., ...

The Sydney Bondi Junction mall knife attacker fatally stabbed six people and injured 10 others in just three minutes, an ...

Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...